TY - JOUR
T1 - MEETING HIGHLIGHTS
T2 - THE THIRD MARIE SKŁODOWSKA-CURIE SYMPOSIUM ON CANCER RESEARCH AND CARE AT ROSWELL PARK COMPREHENSIVE CANCER CENTER, BUFFALO, NY, SEPTEMBER 20-22, 2023
AU - Kalinski, Pawel
AU - Kokolus, Kathleen M.
AU - Azrak, Rami
AU - Berezin, Mikhail Y.
AU - Brentjens, Renier
AU - Czerniecki, Brian
AU - Dubrov, Sergii
AU - Eaton, Kara
AU - Hyland, Andrew
AU - Kisailus, Adam
AU - Kortylewski, Marcin
AU - Koski, Gary K.
AU - Kotula, Leszek
AU - Gandhi, Shipra
AU - Griffiths, Elizabeth A.
AU - Ługowska, Iwona
AU - Matosevic, Sandro
AU - McAleer, Christopher
AU - Mikuła, Michał
AU - Nishimura, Michael I.
AU - Noyes, Katie
AU - Orabina, Tetiana
AU - Ozretić, Petar
AU - Paragh, Gyorgy
AU - Parascandola, Mark
AU - Pašukonienė, Vita
AU - Perl, Andras
AU - Powell, Daniel J.
AU - Priebe, Waldemar
AU - Repasky, Elizabeth A.
AU - Rudnicki, Marek
AU - Singh, Anurag K.
AU - Sarnowska, Elżbieta
AU - Sužiedėlis, Kęstutis
AU - Titkova, Anna
AU - Utz, Karen
AU - Wei, Wei Zen
AU - Rutkowski, Piotr
PY - 2023
Y1 - 2023
N2 - Marie Skłodowska-Curie Symposia on Cancer Research and Care (MSCS-CRC) promote collaborations between cancer researchers and care providers in the United States, Canada and Central and Eastern European Countries (CEEC), to accelerate the development of new cancer therapies, advance early detection and prevention, increase cancer awareness, and improve cancer care and the quality of life of patients and their families. The third edition of MSCS-CRC, held at Roswell Park Comprehensive Cancer Center, Buffalo, NY, in September 2023, brought together 137 participants from 20 academic institutions in the US, Poland, Ukraine, Lithuania, Croatia and Hungary, together with 16 biotech and pharma entities. The key areas of collaborative opportunity identified during the meeting are a) creating of a database of available collaborative projects in the areas of early-phase clinical trials, preclinical development, and identification of early biomarkers; b) promoting awareness of cancer risks and efforts at cancer prevention; c) laboratory and clinical training; and d) sharing experience in cost-effective delivery of cancer care and improving the quality of life of cancer patients and their families. Examples of ongoing international collaborations in the above areas were discussed. Participation of the representatives of the Warsaw-based Medical Research Agency, National Cancer Institute (NCI) of the United States, National Cancer Research Institutes of Poland and Lithuania, New York State Empire State Development, Ministry of Health of Ukraine and Translational Research Cancer Center Consortium of 13 cancer centers from the US and Canada, facilitated the discussion of available governmental and non-governmental funding initiatives in the above areas.
AB - Marie Skłodowska-Curie Symposia on Cancer Research and Care (MSCS-CRC) promote collaborations between cancer researchers and care providers in the United States, Canada and Central and Eastern European Countries (CEEC), to accelerate the development of new cancer therapies, advance early detection and prevention, increase cancer awareness, and improve cancer care and the quality of life of patients and their families. The third edition of MSCS-CRC, held at Roswell Park Comprehensive Cancer Center, Buffalo, NY, in September 2023, brought together 137 participants from 20 academic institutions in the US, Poland, Ukraine, Lithuania, Croatia and Hungary, together with 16 biotech and pharma entities. The key areas of collaborative opportunity identified during the meeting are a) creating of a database of available collaborative projects in the areas of early-phase clinical trials, preclinical development, and identification of early biomarkers; b) promoting awareness of cancer risks and efforts at cancer prevention; c) laboratory and clinical training; and d) sharing experience in cost-effective delivery of cancer care and improving the quality of life of cancer patients and their families. Examples of ongoing international collaborations in the above areas were discussed. Participation of the representatives of the Warsaw-based Medical Research Agency, National Cancer Institute (NCI) of the United States, National Cancer Research Institutes of Poland and Lithuania, New York State Empire State Development, Ministry of Health of Ukraine and Translational Research Cancer Center Consortium of 13 cancer centers from the US and Canada, facilitated the discussion of available governmental and non-governmental funding initiatives in the above areas.
KW - cancer care
KW - cancer prevention
KW - clinical trials
KW - education
KW - research
KW - training
UR - http://www.scopus.com/inward/record.url?scp=85183781727&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85183781727&partnerID=8YFLogxK
U2 - 10.36740/WLek202312101
DO - 10.36740/WLek202312101
M3 - Article
C2 - 38290016
AN - SCOPUS:85183781727
SN - 0043-5147
VL - 76
SP - 2543
EP - 2555
JO - Wiadomosci Lekarskie
JF - Wiadomosci Lekarskie
IS - 12
ER -